CodeMap®  		150 North Wacker Drive
Suite 2360
Chicago, IL 60606
847-381-5465 Phone
847-381-4606 Fax
customerservice@codemap.com
      


User Information

Create New Account

Lost Password

Username:
Password:

Quick Links

LCDs and LCAs
by Contractor

PLA Codes

Laboratory Fee Schedule

2025
2024
QW Tests

Physician Fee Schedule

2025
2024

OPPS Fee Schedule

2025-July
2025-April

ASC Fee Schedule

2025-July
2025-April

APC Codes

2025-July
2025-April

DRG Codes

2025
2024

ASP Drug Pricing Files

2025-July
2025-April


CMS Transmittals



.

ICD-10 Code or Description Search:
Injury, poisoning and certain other consequences of external causes -Back to Parent Categories

Poisoning by, adverse effect of and underdosing of nonopioid analgesics, antipyretics and antirheumatics-Back to Sub Category

ICD-10 CodeDescription
T39.011APoisoning by aspirin, accidental (unintentional), initial encounter
T39.011DPoisoning by aspirin, accidental (unintentional), subsequent encounter
T39.011SPoisoning by aspirin, accidental (unintentional), sequela
T39.012APoisoning by aspirin, intentional self-harm, initial encounter
T39.012DPoisoning by aspirin, intentional self-harm, subsequent encounter
T39.012SPoisoning by aspirin, intentional self-harm, sequela
T39.013APoisoning by aspirin, assault, initial encounter
T39.013DPoisoning by aspirin, assault, subsequent encounter
T39.013SPoisoning by aspirin, assault, sequela
T39.014APoisoning by aspirin, undetermined, initial encounter
T39.014DPoisoning by aspirin, undetermined, subsequent encounter
T39.014SPoisoning by aspirin, undetermined, sequela
T39.015AAdverse effect of aspirin, initial encounter
T39.015DAdverse effect of aspirin, subsequent encounter
T39.015SAdverse effect of aspirin, sequela
T39.016AUnderdosing of aspirin, initial encounter
T39.016DUnderdosing of aspirin, subsequent encounter
T39.016SUnderdosing of aspirin, sequela
T39.091APoisoning by salicylates, accidental (unintentional), initial encounter
T39.091DPoisoning by salicylates, accidental (unintentional), subsequent encounter
T39.091SPoisoning by salicylates, accidental (unintentional), sequela
T39.092APoisoning by salicylates, intentional self-harm, initial encounter
T39.092DPoisoning by salicylates, intentional self-harm, subsequent encounter
T39.092SPoisoning by salicylates, intentional self-harm, sequela
T39.093APoisoning by salicylates, assault, initial encounter
T39.093DPoisoning by salicylates, assault, subsequent encounter
T39.093SPoisoning by salicylates, assault, sequela
T39.094APoisoning by salicylates, undetermined, initial encounter
T39.094DPoisoning by salicylates, undetermined, subsequent encounter
T39.094SPoisoning by salicylates, undetermined, sequela
T39.095AAdverse effect of salicylates, initial encounter
T39.095DAdverse effect of salicylates, subsequent encounter
T39.095SAdverse effect of salicylates, sequela
T39.096AUnderdosing of salicylates, initial encounter
T39.096DUnderdosing of salicylates, subsequent encounter
T39.096SUnderdosing of salicylates, sequela
T39.1X1APoisoning by 4-Aminophenol derivatives, accidental (unintentional), initial encounter
T39.1X1DPoisoning by 4-Aminophenol derivatives, accidental (unintentional), subsequent encounter
T39.1X1SPoisoning by 4-Aminophenol derivatives, accidental (unintentional), sequela
T39.1X2APoisoning by 4-Aminophenol derivatives, intentional self-harm, initial encounter
T39.1X2DPoisoning by 4-Aminophenol derivatives, intentional self-harm, subsequent encounter
T39.1X2SPoisoning by 4-Aminophenol derivatives, intentional self-harm, sequela
T39.1X3APoisoning by 4-Aminophenol derivatives, assault, initial encounter
T39.1X3DPoisoning by 4-Aminophenol derivatives, assault, subsequent encounter
T39.1X3SPoisoning by 4-Aminophenol derivatives, assault, sequela
T39.1X4APoisoning by 4-Aminophenol derivatives, undetermined, initial encounter
T39.1X4DPoisoning by 4-Aminophenol derivatives, undetermined, subsequent encounter
T39.1X4SPoisoning by 4-Aminophenol derivatives, undetermined, sequela
T39.1X5AAdverse effect of 4-Aminophenol derivatives, initial encounter
T39.1X5DAdverse effect of 4-Aminophenol derivatives, subsequent encounter
T39.1X5SAdverse effect of 4-Aminophenol derivatives, sequela
T39.1X6AUnderdosing of 4-Aminophenol derivatives, initial encounter
T39.1X6DUnderdosing of 4-Aminophenol derivatives, subsequent encounter
T39.1X6SUnderdosing of 4-Aminophenol derivatives, sequela
T39.2X1APoisoning by pyrazolone derivatives, accidental (unintentional), initial encounter
T39.2X1DPoisoning by pyrazolone derivatives, accidental (unintentional), subsequent encounter
T39.2X1SPoisoning by pyrazolone derivatives, accidental (unintentional), sequela
T39.2X2APoisoning by pyrazolone derivatives, intentional self-harm, initial encounter
T39.2X2DPoisoning by pyrazolone derivatives, intentional self-harm, subsequent encounter
T39.2X2SPoisoning by pyrazolone derivatives, intentional self-harm, sequela
T39.2X3APoisoning by pyrazolone derivatives, assault, initial encounter
T39.2X3DPoisoning by pyrazolone derivatives, assault, subsequent encounter
T39.2X3SPoisoning by pyrazolone derivatives, assault, sequela
T39.2X4APoisoning by pyrazolone derivatives, undetermined, initial encounter
T39.2X4DPoisoning by pyrazolone derivatives, undetermined, subsequent encounter
T39.2X4SPoisoning by pyrazolone derivatives, undetermined, sequela
T39.2X5AAdverse effect of pyrazolone derivatives, initial encounter
T39.2X5DAdverse effect of pyrazolone derivatives, subsequent encounter
T39.2X5SAdverse effect of pyrazolone derivatives, sequela
T39.2X6AUnderdosing of pyrazolone derivatives, initial encounter
T39.2X6DUnderdosing of pyrazolone derivatives, subsequent encounter
T39.2X6SUnderdosing of pyrazolone derivatives, sequela
T39.311APoisoning by propionic acid derivatives, accidental (unintentional), initial encounter
T39.311DPoisoning by propionic acid derivatives, accidental (unintentional), subsequent encounter
T39.311SPoisoning by propionic acid derivatives, accidental (unintentional), sequela
T39.312APoisoning by propionic acid derivatives, intentional self-harm, initial encounter
T39.312DPoisoning by propionic acid derivatives, intentional self-harm, subsequent encounter
T39.312SPoisoning by propionic acid derivatives, intentional self-harm, sequela
T39.313APoisoning by propionic acid derivatives, assault, initial encounter
T39.313DPoisoning by propionic acid derivatives, assault, subsequent encounter
T39.313SPoisoning by propionic acid derivatives, assault, sequela
T39.314APoisoning by propionic acid derivatives, undetermined, initial encounter
T39.314DPoisoning by propionic acid derivatives, undetermined, subsequent encounter
T39.314SPoisoning by propionic acid derivatives, undetermined, sequela
T39.315AAdverse effect of propionic acid derivatives, initial encounter
T39.315DAdverse effect of propionic acid derivatives, subsequent encounter
T39.315SAdverse effect of propionic acid derivatives, sequela
T39.316AUnderdosing of propionic acid derivatives, initial encounter
T39.316DUnderdosing of propionic acid derivatives, subsequent encounter
T39.316SUnderdosing of propionic acid derivatives, sequela
T39.391APoisoning by other nonsteroidal anti-inflammatory drugs [NSAID], accidental (unintentional), initial encounter
T39.391DPoisoning by other nonsteroidal anti-inflammatory drugs [NSAID], accidental (unintentional), subsequent encounter
T39.391SPoisoning by other nonsteroidal anti-inflammatory drugs [NSAID], accidental (unintentional), sequela
T39.392APoisoning by other nonsteroidal anti-inflammatory drugs [NSAID], intentional self-harm, initial encounter
T39.392DPoisoning by other nonsteroidal anti-inflammatory drugs [NSAID], intentional self-harm, subsequent encounter
T39.392SPoisoning by other nonsteroidal anti-inflammatory drugs [NSAID], intentional self-harm, sequela
T39.393APoisoning by other nonsteroidal anti-inflammatory drugs [NSAID], assault, initial encounter
T39.393DPoisoning by other nonsteroidal anti-inflammatory drugs [NSAID], assault, subsequent encounter
T39.393SPoisoning by other nonsteroidal anti-inflammatory drugs [NSAID], assault, sequela
T39.394APoisoning by other nonsteroidal anti-inflammatory drugs [NSAID], undetermined, initial encounter
T39.394DPoisoning by other nonsteroidal anti-inflammatory drugs [NSAID], undetermined, subsequent encounter
T39.394SPoisoning by other nonsteroidal anti-inflammatory drugs [NSAID], undetermined, sequela
T39.395AAdverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter
T39.395DAdverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], subsequent encounter
T39.395SAdverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], sequela
T39.396AUnderdosing of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter
T39.396DUnderdosing of other nonsteroidal anti-inflammatory drugs [NSAID], subsequent encounter
T39.396SUnderdosing of other nonsteroidal anti-inflammatory drugs [NSAID], sequela
T39.4X1APoisoning by antirheumatics, not elsewhere classified, accidental (unintentional), initial encounter
T39.4X1DPoisoning by antirheumatics, not elsewhere classified, accidental (unintentional), subsequent encounter
T39.4X1SPoisoning by antirheumatics, not elsewhere classified, accidental (unintentional), sequela
T39.4X2APoisoning by antirheumatics, not elsewhere classified, intentional self-harm, initial encounter
T39.4X2DPoisoning by antirheumatics, not elsewhere classified, intentional self-harm, subsequent encounter
T39.4X2SPoisoning by antirheumatics, not elsewhere classified, intentional self-harm, sequela
T39.4X3APoisoning by antirheumatics, not elsewhere classified, assault, initial encounter
T39.4X3DPoisoning by antirheumatics, not elsewhere classified, assault, subsequent encounter
T39.4X3SPoisoning by antirheumatics, not elsewhere classified, assault, sequela
T39.4X4APoisoning by antirheumatics, not elsewhere classified, undetermined, initial encounter
T39.4X4DPoisoning by antirheumatics, not elsewhere classified, undetermined, subsequent encounter
T39.4X4SPoisoning by antirheumatics, not elsewhere classified, undetermined, sequela
T39.4X5AAdverse effect of antirheumatics, not elsewhere classified, initial encounter
T39.4X5DAdverse effect of antirheumatics, not elsewhere classified, subsequent encounter
T39.4X5SAdverse effect of antirheumatics, not elsewhere classified, sequela
T39.4X6AUnderdosing of antirheumatics, not elsewhere classified, initial encounter
T39.4X6DUnderdosing of antirheumatics, not elsewhere classified, subsequent encounter
T39.4X6SUnderdosing of antirheumatics, not elsewhere classified, sequela
T39.8X1APoisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, accidental (unintentional), initial encounter
T39.8X1DPoisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, accidental (unintentional), subsequent encounter
T39.8X1SPoisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, accidental (unintentional), sequela
T39.8X2APoisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, intentional self-harm, initial encounter
T39.8X2DPoisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, intentional self-harm, subsequent encounter
T39.8X2SPoisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, intentional self-harm, sequela
T39.8X3APoisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, assault, initial encounter
T39.8X3DPoisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, assault, subsequent encounter
T39.8X3SPoisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, assault, sequela
T39.8X4APoisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, undetermined, initial encounter
T39.8X4DPoisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, undetermined, subsequent encounter
T39.8X4SPoisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, undetermined, sequela
T39.8X5AAdverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, initial encounter
T39.8X5DAdverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, subsequent encounter
T39.8X5SAdverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, sequela
T39.8X6AUnderdosing of other nonopioid analgesics and antipyretics, not elsewhere classified, initial encounter
T39.8X6DUnderdosing of other nonopioid analgesics and antipyretics, not elsewhere classified, subsequent encounter
T39.8X6SUnderdosing of other nonopioid analgesics and antipyretics, not elsewhere classified, sequela
T39.91XAPoisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, accidental (unintentional), initial encounter
T39.91XDPoisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, accidental (unintentional), subsequent encounter
T39.91XSPoisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, accidental (unintentional), sequela
T39.92XAPoisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, intentional self-harm, initial encounter
T39.92XDPoisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, intentional self-harm, subsequent encounter
T39.92XSPoisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, intentional self-harm, sequela
T39.93XAPoisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, assault, initial encounter
T39.93XDPoisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, assault, subsequent encounter
T39.93XSPoisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, assault, sequela
T39.94XAPoisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, undetermined, initial encounter
T39.94XDPoisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, undetermined, subsequent encounter
T39.94XSPoisoning by unspecified nonopioid analgesic, antipyretic and antirheumatic, undetermined, sequela
T39.95XAAdverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, initial encounter
T39.95XDAdverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, subsequent encounter
T39.95XSAdverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, sequela
T39.96XAUnderdosing of unspecified nonopioid analgesic, antipyretic and antirheumatic, initial encounter
T39.96XDUnderdosing of unspecified nonopioid analgesic, antipyretic and antirheumatic, subsequent encounter
T39.96XSUnderdosing of unspecified nonopioid analgesic, antipyretic and antirheumatic, sequela

CodeMap¨ is a Registered Trademark of Wheaton Partners, LLC.